Johns Hopkins spinout AsclepiX Therapeutics Inc. will use the new funding to support clinical trials of its lead drug candidate.
from https://www.bizjournals.com/baltimore/news/2020/06/25/baltimore-blindness-fighting-drug-firm-raises-35-m.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/621898019585114112
No comments:
Post a Comment